New injection could tame seasonal allergy symptoms for those failed by standard treatments
NCT ID NCT07688772
First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time
Summary
This Phase 3 trial tests an investigational injection called SHR-1819 in adults aged 18 to 75 with seasonal allergic rhinitis (hay fever) who haven't gotten enough relief from standard treatments like nasal sprays or antihistamines. The study compares the drug to a placebo to see if it reduces nasal symptoms such as sneezing and congestion, as well as eye symptoms, over two to four weeks. Researchers will also monitor safety and how the body processes the drug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SHR-1819 injection
- What this could lead to
- If effective, SHR-1819 could offer a new treatment option for people with seasonal allergies who don't get relief from standard nasal sprays or antihistamines.
- What could go wrong
- This is an early Phase 3 trial, so the drug may not prove more effective than placebo. Side effects are possible, and results may not apply to all allergy sufferers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEASONAL ALLERGIC RHINITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, 100005, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pinpoint pollen dose unmask allergy triggers?
- New allergy pill could offer relief from sneezing and stuffy nose
- New shot for teen hay fever? early trial underway
- Nasal spray test could make allergy shots smarter and cheaper
- New allergy drug AK139 aims to stop sneezing and stuffy noses
- New shot could tame seasonal sniffles for good?